GlassScriptPhysician profile
Meghan Bhave
NPI 1851679591
$3,250.95
in general payments reported to CMS, 2019-2025
39 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $436 · 2021: $618 · 2022: $283 · 2023: $430 · 2024: $187 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $482.84 | 2020-2025 | Proclaim, Eterna, Axium |
| Nevro Corp. | $262.52 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $256.71 | 2019-2023 | Intracept |
| Biodelivery Sciences International, INC. | $243.84 | 2019-2021 | |
| Spinal Simplicity, LLC | $190.85 | 2022-2025 | Ha Minuteman G3-R |
| Pfizer INC. | $175.10 | 2019-2021 | |
| Fidia Pharma USA INC. | $171.41 | 2021-2025 | Hymovis, Triluron, Hyalgan |
| Electronic Waveform Lab, INC. | $152.15 | 2019 | |
| Vertiflex, INC. | $111.10 | 2019 | |
| Stratus Medical, LLC | $107.33 | 2020 | |
| Boston Scientific Corporation | $105.47 | 2019-2025 | General - Pain Management |
| Assertio Therapeutics, INC. | $74.96 | 2019 | |
| Horizon Therapeutics Plc | $74.76 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $69.35 | 2019 | |
| Daiichi Sankyo INC. | $66.61 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $66.15 | 2021-2023 | Kyphon Express II Kyphopak Tray |
| Scilex Pharmaceuticals INC. | $54.21 | 2019-2024 | |
| Almatica Pharma LLC | $49.71 | 2021 | |
| Sentynl Therapeutics, INC. | $48.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $42.10 | 2024-2025 | |
| Janssen Biotech, INC. | $40.80 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.96 | 2025 | Relistor |
| Depuy Synthes Sales INC. | $37.60 | 2019 | |
| Si-Bone, INC. | $35.98 | 2019 | |
| Shionogi INC | $30.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.09 | 2019 | |
| Averitas Pharma INC. | $27.34 | 2023 | Qutenza |
| Stimwave Technologies Incorporated | $27.04 | 2022 | |
| Amgen INC. | $20.46 | 2019 | |
| Orthogenrx INC. | $18.68 | 2021 | |
| Redhill Biopharma INC. | $18.56 | 2020 | |
| Nalu Medical, INC. | $17.92 | 2021 | |
| Virtus Pharmaceuticals LLC | $16.47 | 2021 | |
| Pacira Therapeutics, INC. | $15.97 | 2021 | |
| Teleflex LLC | $14.83 | 2025 | Arrow |
| Medtronic USA, INC. | $14.45 | 2020 | |
| Kaleo, INC. | $14.45 | 2019 | |
| Ibsa Pharma INC. | $13.82 | 2024 | Tirosint, Licart, Flector |
| Zyla Life Sciences, INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Bhave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.